Company Filing History:
Years Active: 1997
Title: Rolf Emil Amsler: Innovator in Therapeutic Compounds
Introduction
Rolf Emil Amsler is a notable inventor based in Allerød, Denmark. He has made significant contributions to the field of medicinal chemistry, particularly in the development of therapeutic agents. His work has led to advancements that may benefit various medical applications.
Latest Patents
Rolf Emil Amsler holds a patent for "Acid addition salts of 2, 3, 4, 5-tetrahydro-1H-3-benzazepine compounds." This invention provides a series of crystalline salts of (S)-8-chloro-5-(5-bromo-2,3-dihydrobenzofuran-7-yl)-3-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine-7-ol. The preparation and use of these compounds as therapeutic agents represent a significant advancement in the field.
Career Highlights
Rolf Emil Amsler is associated with Novo Nordisk A/S, a leading global healthcare company. His role at the company has allowed him to focus on innovative solutions in the pharmaceutical industry. His expertise in medicinal chemistry has been instrumental in the development of new therapeutic agents.
Collaborations
Throughout his career, Rolf has collaborated with notable colleagues, including Louis B. Hansen and Scott E. McGraw. These collaborations have fostered an environment of innovation and have contributed to the success of various projects.
Conclusion
Rolf Emil Amsler's contributions to the field of medicinal chemistry and his innovative patent work highlight his importance as an inventor. His ongoing efforts in developing therapeutic agents continue to pave the way for advancements in healthcare.